Nevro And Medtronic Announce FDA Approval Of Spinal Cord Stimulation Label Expansions

The FDA approved a diabetic peripheral neuropathy indication for Medtronic’s Intellis and Vanta spinal cord stimulators a few days after expanding the indication for Senza Nevro’s spinal cord stimulation system to include non-surgical refractory back pain.